Different Stakeholder Perspectives On Pharmacogenomic Testing
نویسندگان
چکیده
منابع مشابه
Stakeholder perspectives on a risk-benefit framework for genetic testing.
A key to accelerating the appropriate integration of genomic applications into healthcare in the coming decades will be the ability to assess the tradeoffs between clinical benefits and clinical risks of genetic tests in a timely manner. Several factors limit the ability of stakeholders to achieve this objective, including the lack of direct evidence, the lack of a framework to quantitatively a...
متن کاملStakeholder Perspectives on California's Nurse Staffing Crisis
The state’s demand for nurses is projected to exceed supply by 25,000 over the next two decades. Causes of this shortfall are both numerous and complex. Mounting financial pressure on health care employers has led many to cut nursing staff, increasing the workloads and stress levels of those who remain. Within hospital settings, nurses complain they are no longer able to spend sufficient time c...
متن کاملEvolving research and stakeholder perspectives on pharmacogenomics.
THE PAST DECADE HAS BEEN A TIME OF IMPORTANT change in pharmacogenomics. There is an increasingly clear understanding of the relationship between genetic variation and drug response, lowcost testing technologies are becoming available, and pharmacogenomics is playing an increasing role in drug development. Key stakeholders in the US health care system are responding to these changes in various ...
متن کاملStakeholder perspectives on relationship between factors affecting readiness for radio frequency identification implementation
Introduction: Radio Frequency Identification (RFID) is a type of automatic identification technology which uses radio waves for collecting and transferring data. Due to extensive use in tracking and identifying people and objects, this technology has been able to solve many of the hospital's problems and help to increase the quality of delivery of services. The aim of this study was to survey t...
متن کاملPsychiatric pharmacogenomic testing in clinical practice
The clinical adoption of psychiatric pharmacogenomic testing has taken place rapidly over the past 7 years. Initially, drug-metabolizing enzyme genes, such as the cytochrome P450 2D6 gene (CYP2D6), were identified. Genotyping the highly variable cytochrome P450 2D6 gene now provides clinicians with the opportunity to identify both poor metabolizers and ultrarapid metabolizers of 2D6 substrate m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2013
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.1241